Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 15
Review
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,822 | Dovepress* | 5,325+ | 254 | 5,579 | |
| PubMed Central* | 2,497 | 669 | 3,166 | ||
| Totals | 7,822 | 923 | 8,745 | ||
| *Since 16 August 2022 | |||||
View citations on PubMed Central and Google Scholar